Skip to content
inentertainment.co.uk
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
MEDSIR
MEDSIR presents final TUXEDO-3 results highlighting the potential of patritumab deruxtecan in active brain metastases and leptomeningeal disease
October 26, 2026
A combined therapeutic strategy aims to improve disease control in advanced hormone‑sensitive prostate cancer
June 1, 2026